ADDEX THERAPEUTICS LTD (ADXN) Stock Analyst Earnings Estimates
NASDAQ:ADXN - Nasdaq - US00654J2069 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.153M -18.71% | 1.445M -54.18% | 1.647M 13.99% | 973.59K -40.89% | 765K -21.42% | 765K | 6.908M 803.01% | -100.00% | ||||
| EBITDA YoY % growth | -15.158M -27.76% | -20.197M -33.24% | -9.975M 50.61% | -5.149M 48.38% | -7.395M -43.61% | -7.109M 3.86% | -5.822M 18.10% | -2.819M 51.58% | -2.819M | -2.819M | -2.819M | |
| EBIT YoY % growth | -15.506M -26.65% | -20.52M -32.34% | -10.281M 49.90% | -3.822M 62.83% | -3.437M 10.06% | -2.938M 14.54% | -5.822M -98.20% | -2.819M 51.58% | -2.819M | -2.819M | -2.819M | |
| Operating Margin | -491.73% | -1,420.12% | -624.22% | -392.56% | -449.33% | -384.00% | -84.28% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A 19.08% | -9.54 76.95% | N/A -33.79% | 0.47 103.68% | -5.63 -1,300.00% | -3.75 33.33% | 0.00 100.00% | -0.18 | -0.09 49.87% | 0.04 150.00% | N/A |
All data in CHF
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CHF
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | -21.06 -576.34% | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 58.35K -82.28% | % | ||
| Q2 2024 Q2Q % growth | 115.28K -81.76% | % | ||
| Q1 2024 Q2Q % growth | 241.812K -51.84% | % | ||
| Q4 2023 Q2Q % growth | 183.83K -81.88% | % | ||
| Q3 2023 Q2Q % growth | 329.22K -20.80% | % | ||
| Q2 2023 Q2Q % growth | 631.98K 46.84% | % | ||
| Q1 2023 Q2Q % growth | 502.05K 105.80% | % | ||
| Q4 2022 Q2Q % growth | 1.015M -12.46% | % | ||
| Q3 2022 Q2Q % growth | 415.7K -45.14% | % | ||
| Q2 2022 Q2Q % growth | 430.39K -78.42% | % | ||
| Q1 2022 Q2Q % growth | 243.95K -73.55% | % | ||
| Q4 2021 Q2Q % growth | 1.159M -41.89% | % | ||
| Q3 2021 Q2Q % growth | 757.78K 638.22% | % | ||
| Q2 2021 Q2Q % growth | 1.994M 5.81% | % | ||
| Q1 2021 Q2Q % growth | 922.42K -3.15% | % | ||
| Q4 2020 Q2Q % growth | 1.994M 24.12% | % | ||
| Q2 2020 Q2Q % growth | 1.885M 53.62% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 107.04% | 107.04% |
| Revenue | N/A | N/A | 133.37% | -20.46% |